PIMA548046
Natalizumab Chimeric Recombinant Rabbit Monoclonal Antibody (Natalizumab), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA548046-Each-of-1 | In Stock | ₹ 46,769.50 |
PIMA548046 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,769.50
GST (18%): ₹ 8,418.51
Total Price: ₹ 55,188.01
Antigen
Natalizumab Chimeric
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% ProClin 300
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Target Species
Human
Form
Liquid
Applications
Flow Cytometry, Inhibition Assays
Clone
Natalizumab
Conjugate
Unconjugated
Gene Alias
AN 100226; BG00002
Immunogen
The RAMOS cell line, a non-EBV releasing cell line, injected into mice.
Quantity
200 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG κ
Related Products
Description
- Specificity: This antibody binds to the alpha 4 binds subunit of alpha-4Beta1 (also known as very late antigen 4 [VLA-4] or CD49d-CD29) and alpha-4Beta7 integrin Natalizumab is a recombinant, humanized monoclonal antibody, binds to alpha4beta1-integrinand blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1)
- Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease
- Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.